1-7 of 7
Yan Lin
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

A Novel Third-generation EGFR Tyrosine Kinase Inhibitor Abivertinib for EGFR T790M-mutant Non–Small Cell Lung Cancer: a Multicenter Phase I/II Study

Qing Zhou, Lin Wu, Pei Hu, Tongtong An, Jianying Zhou, Li Zhang, Xiao-Qing Liu, Feng Luo, Xin Zheng, Ying Cheng, Nong Yang, Junling Li, Jifeng Feng, Baohui Han, Yong Song, Kai Wang, Li Zhang, Jian Fang, Hong Zhao, Yongqian Shu, Xiao-Yan Lin, Zhihong Chen, Bin Gan, Wan-Hong Xu, Wei Tang, Xiaoying Zhang, Jin-Ji Yang, Xiao Xu, Yi-Long Wu
Journal: Clinical Cancer Research
Clin Cancer Res (2022) 28 (6): 1127–1135.
https://doi.org/10.1158/1078-0432.CCR-21-2595
Published: 15 March 2022
View articletitled, A Novel Third-generation EGFR Tyrosine Kinase Inhibitor Abivertinib for EGFR T790M-mutant Non–Small Cell Lung Cancer: a Multicenter Phase I/II Study
Open the PDF for A Novel Third-generation EGFR Tyrosine Kinase Inhibitor Abivertinib for EGFR T790M-mutant Non–Small Cell Lung Cancer: a Multicenter Phase I/II Study in another window
Includes: Supplementary data
Journal Articles

Neoadjuvant Pembrolizumab and High-Dose IFNα-2b in Resectable Regionally Advanced Melanoma

Yana G. Najjar, Dustin McCurry, Huang Lin, Yan Lin, Yan Zang, Diwakar Davar, Arivarasan Karunamurthy, Joseph J. Drabick, Rogerio I. Neves, Lisa H. Butterfield, Marc S. Ernstoff, Igor Puzanov, Joseph J. Skitzki, Jennifer Bordeaux, IlaSri B. Summit, Jehovana O. Bender, Ju Young Kim, Beiru Chen, Ghanashyam Sarikonda, Anil Pahuja, Jennifer Tsau, Zeni Alfonso, Christian Laing, James F. Pingpank, Matthew P. Holtzman, Cindy Sander, Amy Rose, Hassane M. Zarour, John M. Kirkwood, Ahmad A. Tarhini
Journal: Clinical Cancer Research
Clin Cancer Res (2021) 27 (15): 4195–4204.
https://doi.org/10.1158/1078-0432.CCR-20-4301
Published: 01 August 2021
View articletitled, Neoadjuvant Pembrolizumab and High-Dose IFNα-2b in Resectable Regionally Advanced Melanoma
Open the PDF for Neoadjuvant Pembrolizumab and High-Dose IFNα-2b in Resectable Regionally Advanced Melanoma in another window
Includes: Supplementary data
Journal Articles

Abstract PR05: APOBEC mutagenesis is tightly linked to the immune landscape and immunotherapy biomarkers in head and neck squamous cell carcinoma

Yan Lin, Shuyan Zhai, Fengshen Kuo, Timothy A. Chan, Luc G. Morris, Robert L. Ferris, Daniel L. Faden, Fei Ding
Journal: Clinical Cancer Research
Clin Cancer Res (2020) 26 (12_Supplement_2): PR05.
https://doi.org/10.1158/1557-3265.AACRAHNS19-PR05
Published: 15 June 2020
View articletitled, Abstract PR05: APOBEC mutagenesis is tightly linked to the immune landscape and immunotherapy biomarkers in head and neck squamous cell carcinoma
Journal Articles

Intratumor Heterogeneity Affects Gene Expression Profile Test Prognostic Risk Stratification in Early Breast Cancer

Rekha Gyanchandani, Yan Lin, Hui-Min Lin, Kristine Cooper, Daniel P. Normolle, Adam Brufsky, Michael Fastuca, Whitney Crosson, Steffi Oesterreich, Nancy E. Davidson, Rohit Bhargava, David J. Dabbs, Adrian V. Lee
Journal: Clinical Cancer Research
Clin Cancer Res (2016) 22 (21): 5362–5369.
https://doi.org/10.1158/1078-0432.CCR-15-2889
Published: 31 October 2016
View articletitled, Intratumor Heterogeneity Affects Gene Expression Profile Test Prognostic Risk Stratification in Early Breast Cancer
Open the PDF for Intratumor Heterogeneity Affects Gene Expression Profile Test Prognostic Risk Stratification in Early Breast Cancer in another window
Includes: Supplementary data
Journal Articles

Abstract B20: Prediction of lung cancer survival by genes in the PAM50 breast cancer panel.

Jill M. Siegfried, Yan Lin, Sanja Dacic, Brenda Diergaarde, Laura P. Stabile, Hui-Min Lin, Marjorie Romkes
Journal: Clinical Cancer Research
Clin Cancer Res (2014) 20 (2_Supplement): B20.
https://doi.org/10.1158/1078-0432.14AACRIASLC-B20
Published: 16 January 2014
View articletitled, Abstract B20: Prediction of lung cancer survival by genes in the PAM50 breast cancer panel.
Journal Articles

Plasma MicroRNAs as Novel Biomarkers for Endometriosis and Endometriosis-Associated Ovarian Cancer

Swati Suryawanshi, Anda M. Vlad, Hui-Min Lin, Gina Mantia-Smaldone, Robin Laskey, MinJae Lee, Yan Lin, Nicole Donnellan, Marcia Klein-Patel, Ted Lee, Suketu Mansuria, Esther Elishaev, Raluca Budiu, Robert P. Edwards, Xin Huang
Journal: Clinical Cancer Research
Clin Cancer Res (2013) 19 (5): 1213–1224.
https://doi.org/10.1158/1078-0432.CCR-12-2726
Published: 03 March 2013
View articletitled, Plasma MicroRNAs as Novel Biomarkers for Endometriosis and Endometriosis-Associated Ovarian Cancer
Open the PDF for Plasma MicroRNAs as Novel Biomarkers for Endometriosis and Endometriosis-Associated Ovarian Cancer in another window
Includes: Supplementary data
Journal Articles

Tumor Growth Inhibition by Simultaneously Blocking Epidermal Growth Factor Receptor and Cyclooxygenase-2 in a Xenograft Model

Xin Zhang, Zhuo (Georgia) Chen, Mi Sun Choe, Yan Lin, Shi-Yong Sun, H. Samuel Wieand, Hyung Ju C. Shin, Amy Chen, Fadlo R. Khuri, Dong M. Shin
Journal: Clinical Cancer Research
Clin Cancer Res (2005) 11 (17): 6261–6269.
https://doi.org/10.1158/1078-0432.CCR-04-2102
Published: 06 September 2005
View articletitled, Tumor Growth Inhibition by Simultaneously Blocking Epidermal Growth Factor Receptor and Cyclooxygenase-2 in a Xenograft Model
Open the PDF for Tumor Growth Inhibition by Simultaneously Blocking Epidermal Growth Factor Receptor and Cyclooxygenase-2 in a Xenograft Model in another window